Antidiuresis therapy: mechanism of action and clinical implications.
Abnormalities of micturition occur in many different diseases, have a variety of causes and take several forms. This review will focus exclusively on those abnormalities in which antidiuretic therapy may be of benefit. These conditions are primarily characterized by an increase in the total amount of urine produced (polyuria) or a circadian shift in the control of urine production and/or voiding (nocturnal enuresis, nocturia).
Nørgaard
Jens Peter
JP
Ferring Pharmaceuticals A/S, Copenhagen, Denmark. jens.peter.norgaard@ferring.com
Hashim
Hashim
H
Malmberg
Lars
L
Robinson
Dudley
D
D050034:Antidiuretic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D053206:Nocturnal Enuresis / Q000188:drug therapy* / Q000503:physiopathology; D011141:Polyuria / Q000188:drug therapy* / Q000503:physiopathology; D011788:Quality of Life; D014555:Urination Disorders / Q000188:drug therapy / Q000503:physiopathology; D014867:Water / Q000378:metabolism
D050034:Antidiuretic Agents; D014867:Water; D003894:Deamino Arginine Vasopressin